CRMP2 derived from cancer associated fibroblasts facilitates progression of ovarian cancer via HIF-1α-glycolysis signaling pathway
2022 · Cell Death and Disease · 40 citations
https://doi.org/10.1038/s41419-022-05129-5
J
Jiahang Mo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
415
Citations
12
h-index
13
i10-index
Jiahang Mo is an academic researcher from Obstetrics and Gynecology Hospital of Fudan University. The author has contributed to research in topics: Inflammatory Biomarkers in Disease Prognosis & Cancer Immunotherapy and Biomarkers & Gastric Cancer Management and Outcomes. The author has an h-index of 12, co-authored 20 publications.
ORCID: 0000-0002-2418-1745Papers by this author
worksClinical significance of peripheral blood-derived inflammation markers in advanced gastric cancer after radical resection
2020 · BMC Surgery · 35 citations
https://doi.org/10.1186/s12893-020-00884-8
The efficacy and safety of the addition of poly ADP-ribose polymerase (PARP) inhibitors to therapy for ovarian cancer: a systematic review and meta-analysis
2020 · World Journal of Surgical Oncology · 24 citations
https://doi.org/10.1186/s12957-020-01931-7
CD47—a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features
2024 · World Journal of Surgical Oncology · 19 citations
https://doi.org/10.1186/s12957-024-03308-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat